What don't you like about it? Would you rather them dilute by 6 million shares? The interest rate? What do you expect it to be for a loan to a pre- revenue, OTC biotech? The fact that they agreed to a $10 convertible price is encouraging, and awesome.....again for a pre-revenue, OTC biotech